CRP and myocardial infarction: This systematic review and meta-analysis showed that the statins are efficacious in reducing the concentrations of CRP and Hs-CRP in patients with different types of cardiovascular diseases and coronary artery diseases like acute coronary syndrome, myocardial infarction, stable atherosclerotic plaques, and unstable angina.